Department of Medicine and Surgery, University of Parma, Parma, Italy.
Protein Phosphorylation Laboratory, Francis Crick Institute, London, United Kingdom.
Mol Cancer Res. 2018 Jan;16(1):3-15. doi: 10.1158/1541-7786.MCR-17-0244. Epub 2017 Oct 11.
To form a proper mitotic spindle, centrosomes must be duplicated and driven poleward in a timely and controlled fashion. Improper timing of centrosome separation and errors in mitotic spindle assembly may lead to chromosome instability, a hallmark of cancer. Protein kinase C epsilon (PKCε) has recently emerged as a regulator of several cell-cycle processes associated with the resolution of mitotic catenation during the metaphase-anaphase transition and in regulating the abscission checkpoint. However, an engagement of PKCε in earlier (pre)mitotic events has not been addressed. Here, we now establish that PKCε controls prophase-to-metaphase progression by coordinating centrosome migration and mitotic spindle assembly in transformed cells. This control is exerted through cytoplasmic dynein function. Importantly, it is also demonstrated that the PKCε dependency of mitotic spindle organization is correlated with the nonfunctionality of the TOPO2A-dependent G checkpoint, a characteristic of many transformed cells. Thus, PKCε appears to become specifically engaged in a programme of controls that are required to support cell-cycle progression in transformed cells, advocating for PKCε as a potential cancer therapeutic target. The close relationship between PKCε dependency for mitotic spindle organization and the nonfunctionality of the TOPO2A-dependent G checkpoint, a hallmark of transformed cells, strongly suggests PKCε as a therapeutic target in cancer. .
为了形成一个适当的有丝分裂纺锤体,中心体必须被复制并及时、受控地向两极驱动。中心体分离的时间不当和有丝分裂纺锤体组装的错误可能导致染色体不稳定,这是癌症的一个标志。蛋白激酶 C ɛ(PKCε)最近被认为是与有丝分裂后期-末期过渡期间解决有丝分裂连环以及调节分裂终点检查点相关的几个细胞周期过程的调节剂。然而,PKCε 在早期(前)有丝分裂事件中的参与尚未得到解决。在这里,我们现在确定 PKCε 通过协调转化细胞中的中心体迁移和有丝分裂纺锤体组装来控制前期到中期的进展。这种控制是通过细胞质动力蛋白功能发挥的。重要的是,还证明了 PKCε 对有丝分裂纺锤体组织的依赖性与拓扑异构酶 2A 依赖性 G 检查点的非功能性相关,这是许多转化细胞的特征。因此,PKCε 似乎专门参与了支持转化细胞细胞周期进展所需的控制程序,提倡 PKCε 作为一种潜在的癌症治疗靶点。PKCε 对有丝分裂纺锤体组织的依赖性与拓扑异构酶 2A 依赖性 G 检查点的非功能性之间的密切关系,这是转化细胞的一个标志,强烈表明 PKCε 是癌症治疗的一个潜在靶点。